Strengthening Coordination Among Equipment through the Absorption-Type Merger of JEOL RESONANCE
First written in FY2023-Q1. 1 of 2 entries say "Achieved", first in FY2023-Q3. Latest entry: FY2023-Q3.
No other company in this theme has enough history to compare yet.
- FY2023-Q3AchievedAnnual report
「In addition, on 1 October 2022, the Company conducted an absorption-type merger in which the Company was the surviving company and JEOL RESONANCE, its consolidated subsidiary, was the absorbed company. As a result, JEOL RESONANCE was excluded from the scope of consolidation from the current third-quarter consolidated accounting period.」
The absorption-type merger with JEOL RESONANCE was completed effective 1 October 2022, and the company was excluded from the scope of consolidation. - FY2023-Q1First statedAnnual report
「At a meeting of the Board of Directors held on 31 May 2022, the Company resolved to absorb JEOL RESONANCE, its consolidated subsidiary, in an absorption-type merger effective 1 October 2022, subject to approval at the 75th Annual General Meeting of Shareholders held on 28 June 2022, and entered into a merger agreement on the same date. The merger was approved at the Company's Annual General Meeting of Shareholders held on 28 June 2022. The purpose of the merger is to further strengthen coordination among equipment and provide users with greater added value.」
The Board of Directors' resolution, execution of the merger agreement and shareholder approval were completed for the planned absorption-type merger of JEOL RESONANCE effective 1 October 2022. The stated purpose was to strengthen coordination among high-end measurement and analysis equipment, including NMR and ESR systems and electron microscopes.